Screening of edible Japanese plants for nitric oxide generation inhibitory activities in RAW 264.7 cells

Cancer Letters

Volumn 125, Issue 1-2, 1998, Pages 199-207

  Kim, Oe Kyung ^a   Murakami, Akira ^b   Nakamura, Yoshimasa ^a   Ohigashi, Hajime ^a  

^a KYOTO UNIVERSITY   (Japan)

^b KINKI UNIVERSITY   (Japan)

Author keywords

Cancer chemoprevention; Edible plants; Nitric oxide; Raw 264.7 cells

Indexed keywords

GAMMA INTERFERON; LIPOPOLYSACCHARIDE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; PLANT EXTRACT;

ANIMAL CELL; ARTICLE; CELL LINE; CELL VIABILITY; JAPAN; MACROPHAGE; MOUSE; NONHUMAN; PLANT; PRIORITY JOURNAL;

ANIMALS; CELL LINE; INTERFERON TYPE II; LIPOPOLYSACCHARIDES; MACROPHAGES; MICE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; PLANTS, EDIBLE;

ANIMALIA; BRASSICA JUNCEA; BRASSICA RAPA SUBSP. RAPA; MURINAE; OCIMUM BASILICUM; PERSEA AMERICANA; VICIA SATIVA;

EID: 18344413203     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3835(97)00513-2     Document Type: Article

References (54)

1. Wattenberg L.W. Chemoprevention of cancer. Cancer Res. 45:1985;1-8.
2. Tanaka T. Cancer chemoprevention. Cancer J. 5:1992;11-16.
3. Hirayama T. Diet and cancer. Nutr. Cancer. 1:1978;67-81.
4. The Alpha-Tocopherol Beta-Carotene Cancer Prevention Study Group The alpha-tocopherol, beta-carotene lung cancer prevention study: design, methods, participant characteristics, and compliance. N. Engl. J. Med. 330:1993;1029-1035.
5. Greenberg E.R., Baron J.A., Tosteson T.D. A clinical trial of antioxidant vitamins to prevent colorectal adenoma. N. Engl. J. Med. 331:1994;141-147.
6. Blot W.J., Li J.-Y., Taylor P.R., Guo W., Dawsey S., Wang G.-Q., Yang C.S., Zheng S.-F., Gail M., Li G.-Y., Yu Y., Liu B.-q., Tangrea J., Sun Y.-h., Liu F., Fraumeni F. Jr., Zhang Y.-H., Li B. Nutrition intervention trials in Linxian, China: supplementation with specific vitamins/mineral combinations, cancer incidence, and disease-specific mortality in the general population. J. Natl. Cancer Inst. 85:1993;1483-1491.
7. Ignarro L.J., Fukuto J.M., Griscavage J.M., Rogers N.E., Byrns R.E. Oxidation of nitric oxide in aqueous solution to nitrite but not nitrate: comparison with enzymatically formed nitric oxide from L-arginine. Proc. Natl. Acad. Sci. USA. 90:1993;8103-8107.
8. Arroyo P.L., Hatch-Pigott V., Mower H.F., Cooney R.V. Mutagenicity of nitric oxide and its inhibition by antioxidants. Mutat. Res. 281:1992;193-202.
9. Wink D.A., Kasprzak K.S., Maragos C.M., Elespuru R.K., Misra M., Dunams T.M., Cebula T.A., Koch W.H., Andrews A.W., Allen J.S., Keefer L.K. DNA deaminating ability and genotoxicity of nitric oxide and its progenitors. Science. 254:1991;1001-1003.
10. Miwa M., Stuehr D.J., Marletta M.A., Wishnok J.S., Tannenbaum S.R. Nitrosation of amines by stimulated macrophages. Carcinogenesis. 8(7):1987;955-958.
11. Oshima H., Tsuda M., Adachi H., Ogura T., Sugimura T., Esumi H. L-Arginine-dependent formation of N-nitrosamines by the cytosol of macrophages activated with lipopolysaccharide and interferon-γ Carcinogenesis. 12(7):1991;1217-1220.
12. Grisham M.B., Ware K., Gilleland H.E., Yamada T. Neutrophil-mediated nitrosamine formation: role of nitric oxide in rats. Gastroenterology. 103:1992;1260-1266.
13. Iyengar R., Stuehr D.J., Marletta M.A. Macrophage synthesis of nitrite, nitrate, and N-nitrosamines: precursors and role of the respiratory burst. Proc. Natl. Acad. Sci. USA. 84:1987;6369-6373.
14. Leaf C.D., Wishnok J.S., Tannenbaum S.R. Endogenous incorporation of nitric oxide from L-arginine into N-nitrosomorpholine. Carcinogenesis. 12(3):1991;537-539.
15. Wu Y., Brouet I., Calmels S., Bartsch H., Ohshima H. Increased endogenous N-nitrosamine and nitrate formation by induction of nitric oxide synthase in rats with acute hepatic injury by Propionibacterium acnes and lipopolysaccharide administration. Carcinogenesis. 14(1):1993;7-10.
16. Ischiropoulos H., Zhu L., Beckman J.S. Peroxynitrite formation from macrophage-derived nitric oxide. Arch. Biochem. Biophys. 298(2):1992;446-451.
17. Xia Y., Zweier J.L. Superoxide and peroxynitrite generation from inducible nitric oxide synthase in macrophages. Proc. Natl. Acad. Sci. USA. 94:1997;6954-6958.
18. Salvemini D., Misko T.P., Masferrer J.L., Seibert K., Currie M.G., Needleman P. Nitric oxide activates cyclooxygenase enzymes. Proc. Natl. Acad. Sci. USA. 90:1993;7240-7244.
19. Landino L.M., Crews B.C., Timmons M.D., Morrow J.D., Marnett L.J. Peroxynitrite, the coupling product of nitric oxide and superoxide, activates prostaglandin biosynthesis. Proc. Natl. Acad. Sci. USA. 93:1996;15069-15074.
20. Pozharisski K.M. The significance of nonspecific injury for colon carcinogenesis in rats. Cancer Res. 35:1975;3824-3830.
21. Kerwin J.F., Heller M. The arginine-nitric oxide pathway: a target for new drugs. Med. Res. Rev. 14(1):1994;23-74.
22. Hibbs J.B., Taintor R.R. Jr., Vavrin Z. Macrophage cytotoxicity: role for L-arginine deiminase and imino nitrogen oxidation to nitrite. Science. 235:1987;473-476.
23. Szabo C., Mitchell A., Thiemermann C., Vane J.R. Nitric oxide-mediated hyporeactivity to noradrenaline precedes the induction of nitric oxide synthase in endotoxin shock. Br. J. Pharmacol. 108:1993;786-792.
24. Tayeh M.A., Marletta M.A. Macrophage oxidation of L-arginine to nitric oxide, nitrite and nitrate. J. Biol. Chem. 264(33):1989;19654-19658.
25. Hansan K., Heesen B.J., Corbett J.A., McDaniel M.L., Chang K., Allison W., Wolffenbuttel B.H.R., Williamson J.R., Tilton R.G. Inhibition of nitric oxide formation by guanidines. Eur. J. Pharmacol. 249:1993;101-106.
26. McCall T.B., Feelisch M., Palmer R.M.J., Moncada S. Identification of N-iminoethyl-L-ornithine as an irreversible inhibitor of nitric oxide synthase in phagocytic cells. Br. J. Pharmacol. 102:1991;234-238.
27. Misko T.P., Moore W.M., Kasten T.P., Nickols G.A., Corbett J.A., Tilton R.G., McDaniel M.L., Williamson J.R., Currie M.G. Selective inhibition of the inducible nitric oxide synthase by aminoguanidine. Eur. J. Pharmacol. 233:1993;119-125.
28. Baydoun A.R., Bogle R.G., Pearson J.D., Mann G.E. Discrimination between L-citrulline and arginine transport in activated murine macrophages: inefficient synthesis of NO from recycling of citrulline arginine. Br. J. Pharmacol. 112:1994;487-492.
29. Ohata T., Fukuda K., Takahashi M., Sugimura T., Wakabayashi K. Suppression of nitric oxide production in lipopolysaccharide-stimulated macrophage cells by ω3 polyunsaturated fatty acids. Jpn. J. Cancer Res. 88:1997;234-237.
30. Koshimizu K., Ohigashi H., Tokuda H., Kondo A., Yamaguchi K. Screening of edible plants against possible anti-tumor promoting activity. Cancer Lett. 39:1988;247-257.
31. Murakami A., Suratwadee J., Koshimizu K., Ohigashi H. Screening for in vitro anti-tumor promoting activities of edible plants from Thailand. Cancer Lett. 95:1995;139-146.
32. Ohigashi H., Sakai Y., Yamaguchi K., Umezaki Z., Koshimizu K. Possible anti-tumor promoting properties of marine algae and in vivo activity of Wakame seaweed extract. Biosci. Biotech. Biochem. 56:1992;994-995.
33. Kondo A., Ohigashi H., Murakami A., Suratwadee J., Koshimizu K. Potent inhibitor of tumor-promoter-induced Epstein-Barr virus activation, 1′-acetoxychavicol acetate from Languas galanga, a traditional Thai condiment. Biosci. Biotech. Biochem. 57:1993;1344-1345.
34. Murakami A., Ohigashi H., Koshimizu K. Possible anti-tumor promoting properties of traditional Thai food items and some of their active constituents. Asia Pacific J. Clin. Nutr. 3:1994;185-191.
35. Ohnishi M., Tanaka T., Makita H., Kawamori T., Mori H., Satoh K., Hara A., Murakami A., Ohigashi H., Koshimizu H. Chemopreventive effect of a xanthine oxidase inhibitor, 1′-acetoxychavicol acetate, on rat oral carcinogenesis. Jpn. J. Cancer Res. 87:1996;349-356.
36. Tanaka T., Makita H., Kawamori T., Kawabata K., Murakami A., Satoh K., Hara A., Ohigashi H., Koshimizu K. A xanthine oxidase inhibitor 1′-acetoxychavicol acetate inhibits azoxymethane-induced colonic aberrant crypt foci in rats. Carcinogenesis. 18:1997;1113-1118.
37. Murakami A., Ohura S., Nakamura Y., Koshimizu K., Ohigashi H. 1′-Acetoxychavicol acetate, a superoxide anion generation inhibitor, potently inhibits tumor promotion in ICR mouse skin. Oncology. 53(5):1996;386-391.
38. H. Ohigashi, A. Murakami, K. Koshimizu, Anti-tumor promoters from edible plants, in: C.T. Ho, T. Osawa, M.-T., Hang, R.T. Rosen (Eds.), Food Phytochemicals for Cancer Chemoprevention II, ACS Symposium Series 547, 1994, pp. 251-263.
39. Murakami A., Kondo A., Nakamura Y., Ohigashi H., Koshimizu K. Possible antitumor promoting properties from edible plants of Thailand, and identification of an active constituent, cardamonin, of Boesenbergia pandurata. Biosci. Biotech. Biochem. 57:1992;1971-1973.
40. Murakami A., Nakamura Y., Koshimizu K., Ohigashi H. Glyceroglycolipids from Citrus hystrix, a traditional herb in Thailand, potently inhibit the tumor-promoting activity of 12-O-tetradecanoylphorbol 13-acetate in mouse skin. J. Agric. Food Chem. 43:1995;2779-2783.
41. Nakamura Y., Murakami A., Koshimizu K., Ohigashi H. Identification of pheophorbide a and its related compounds as possible anti-tumor promoters in the leaves of Neptunia oleracea. Biosci. Biotech. Biochem. 60:1996;1028-1030.
42. Nakamura Y., Murakami A., Koshimizu K., Ohigashi H. Inhibitory effect of pheophorbide a, a chlorophyll-related compound on skin tumor promotion in ICR mouse. Cancer Lett. 108:1996;247-255.
43. Murakami A., Kuki W., Takahashi Y., Yonei H., Nakamura Y., Ohto Y., Ohigashi H., Koshimizu K. Auraptene, a citrus coumarin, inhibits 12-O-tetradecanoylphorbol-13-acetate-induced tumor promotion in ICR mouse skin, possibly through suppression of superoxide generation in leukocytes. Jpn. J. Cancer Res. 88:1997;443-452.
44. Sladowski D., Steer S.J., Clothier R.H., Balls M. An improved MTT assay. J. Immunol. Methods. 157:1992;203-207.
45. Boyde T.R.C., Rahmatullah M. Optimization of conditions for the colorimetric determination of citrulline, using diacetyl monoxime. Anal. Biochem. 107:1980;424-431.
46. 15N]nitrite in biological fluids. Anal. Biochem. 126:1982;131-138.
47. Lowenstein C.J., Alley E.W., Raval P., Snowman A.M., Snyder S.H., Russell S.W., Murphy W.J. Macrophage nitric oxide synthase: two upstream regions mediate induction by interferon γ and lipopolysaccharide. Proc. Natl. Acad. Sci. USA. 90:1993;9730-9734.
48. Nakayama I., Kawahara Y., Tsuda T., Okuda M., Yokoyama M. Angiotensin II inhibits cytokine-stimulated inducible nitric oxide synthase expression in vascular smooth muscle cells. J. Biol. Chem. 269:1994;11628-11633.
49. Spink J., Cohen J., Evans T.J. The cytokine responsive vascular smooth muscle cell enhancer of inducible nitric oxide synthase. J. Biol. Chem. 270:1995;29541-29547.
50. Szabo C., Southan G., Thiemermann C. Beneficial effects and improved survival in rodent models of septic shock with S-methylisothiourea sulfate, a potent and selective inhibitor of inducible nitric oxide synthase. Proc. Natl. Acad. Sci. USA. 91:1994;12472-12476.
51. Szabo C., Mitchell J.A., Thiemermann C., Vane J.R. Nitric oxide-mediated hyporeactivity to noradrenaline precedes the induction of nitric oxide synthase in endotoxin shock. Br. J. Pharmacol. 108:1993;786-792.
52. Chan M.M.-Y., Ho C.-T., Huang H.-I. Effects of three dietary phytochemicals from tea, rosemary and turmeric on inflammation-induced nitrite production. Cancer Lett. 96:1995;23-29.
53. Thomsen L.L., Scott J.M., Topley P., Knowles R.G., Keerie A.J., Frend A.J. Selective inhibition of inducible nitric oxide synthase inhibits tumor growth in vivo: studies with 1400W, a novel inhibitor. Cancer Res. 57:1997;3300-3304.
54. Takahashi M., Fukuda K., Ohata T., Sugimura T., Wakabayashi K. Increased expression of inducible and endothelial constitutive nitric oxide synthases in rat colon tumors induced by azoxymethane. Cancer Res. 57:1997;1233-1237.